Cargando…
Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)
BACKGROUND: Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy among young women. Insulin resistance is a key feature in the pathogenesis of PCOS; also high molecular weight adiponectin is a marker of insulin resistance. The aim of this study was to evaluate the insulin resistance,...
Autores principales: | Shirazi, Farnaz Kamali Haghighi, Khodamoradi, Zohre, Jeddi, Marjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941970/ https://www.ncbi.nlm.nih.gov/pubmed/33750349 http://dx.doi.org/10.1186/s12902-021-00710-z |
Ejemplares similares
-
COVID-19 and Acute Pulmonary Embolism in Postpartum Patient
por: Khodamoradi, Zohre, et al.
Publicado: (2020) -
Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients
por: Layegh, Parvin, et al.
Publicado: (2016) -
Urinary Metabolites Reveal Hyperinsulinemia and Insulin Resistance in Polycystic Ovarian Syndrome (PCOS)
por: Fulghesu, Anna Maria, et al.
Publicado: (2021) -
The effects of weight loss on health-related quality of life in obese women with PCOS and controls
por: Shishehgar, Farnaz, et al.
Publicado: (2023) -
Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
por: Oróstica, Maria Lorena, et al.
Publicado: (2022)